Patents
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
04/2009
04/09/2009WO2005017117A3 Multipotent amniotic fetal stem cells (mafsc) and banking of same
04/09/2009WO2005007821A3 Tertiary structures of ica-1/lfa-1 modulators
04/09/2009WO2005001061A3 Polynucleotides encoding novel adiponectin receptor variants
04/09/2009WO2004083395A3 Transporters and ion channels
04/09/2009US20090092601 HUMANIZED ANTI-LT-beta-R ANTIBODIES
04/08/2009EP2045267A2 Humanized antibodies that recognize beta amyloid peptide
04/08/2009CN100475959C Coagulation factor VII anamorphosis
04/08/2009CN100475953C Pancreatic stem cells
04/07/2009US7514595 Targeted and regional cellular ablation in zebrafish
04/07/2009US7514212 Nucleic acid amplification using non-standard bases
04/07/2009CA2210871C Human dnase i variants
04/02/2009WO2005054433A3 A novel “cleave-n-read” system for protease activity assay and methods of use thereof
04/02/2009WO2005047477A3 Interspersed repetitive element rnas as substrates, inhibitors and delivery vehicles for rnai
04/02/2009WO2005044991A3 Compositions and methods of use for a fibroblast growth factor
04/02/2009WO2005044974A3 Cell death-related nucleases and their uses
04/02/2009WO2005033292A3 Methods of establishing intercellular communication in an endothelial cell layer and uses thereof
04/02/2009WO2005033291A3 Hormone response element binding transregulators
04/02/2009WO2005030930A3 Variants of cyan fluorescent protein with improved fluorescent properties
04/02/2009WO2005023986A3 Microrna as ligands and target molecules
04/02/2009WO2005019430A3 In vitro selection of aptamer beacons
04/02/2009WO2005001060A3 Novel calcium channel
04/02/2009WO2004094591A3 Three-dimensional structures of hdac9 and cabin1 and compound structures and methods related thereto
04/02/2009US20090088982 Co-detection of single polypeptide and polynucleotide molecules
04/02/2009US20090087430 Selective inhibition of toll-like receptor-2
04/02/2009US20090087429 IL-17 homologous polypeptides and therapeutic uses thereof
04/02/2009US20090087356 Microfluidic Rotary Flow Reactor Matrix
04/01/2009CN100473723C Amplifying repetitive nucleic acid sequences
03/2009
03/31/2009US7511130 Chimeric rice Os-TubA-3 promoter and methods of use
03/31/2009US7511128 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts
03/31/2009US7510708 Disruption of the REG pathway
03/26/2009WO2005044977A3 Compositions, splice variants and methods relating to lung specific genes and proteins
03/26/2009WO2005030924A3 Genetic markers for skatole metabolism
03/26/2009WO2005017096A3 SPLICE VARIANTS OF ErbB LIGANDS, COMPOSITIONS AND USES THEREOF
03/26/2009WO2005010141A3 Compositions for purifying and crystallizing molecules of interest
03/26/2009WO2004104161A3 Methods and systems for identifying naturally occurring antisense transcripts and methods, kits and arrays utilizing same
03/26/2009WO2004096993A3 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
03/26/2009WO2004087871A3 Method of determining gene expression: targeted expressed gene display
03/26/2009US20090082975 Method of selecting an active oligonucleotide predictive model
03/26/2009US20090081791 Intracellular delivery of small molecules, proteins, and nucleic acids
03/26/2009US20090081762 Superactive Cellulase Formulation Using Cellobiohydrolase-1 from Penicillium Funiculosum
03/25/2009EP2039761A1 Influenza vaccine composition
03/25/2009EP1633854B1 Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium
03/25/2009CN100471946C Process for the biological production of 1,3-propanediol with high yield
03/24/2009US7507875 transforming plant cells with a DNA construct comprising nucleic acid sequences, Eucalyptus caffeic acid 3-O-methyltransferase (COMT) promoters and nucleic acid sequence that code for polypeptides, then culturing said transformed plant cells, to producing transgenic plants
03/24/2009US7507859 Quaternary ammonium compound having ester and/or amide groups; cationic amphiphilic molecule or macromolecule that transforms from a cationic entity to an anionic, neutral, or zwitterionic entity by a chemical, photochemical, or biological reaction and its use for delivery of nucleic acids
03/24/2009US7507795 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases
03/24/2009US7507726 Antibiotic; bactericides
03/19/2009WO2005010162A3 Automated cell culture system and process
03/19/2009US20090075889 Iren protein, its preparation and use
03/19/2009US20090075830 System for identifying and analyzing expression of are-containing genes
03/19/2009US20090075336 Variant Humicola Grisea CBH1.1
03/18/2009CN101389213A Pufa polyketide synthase systems and uses thereof
03/18/2009CN101386855A Nucleotide sequences regulating gene expression and constructs and methods utilizing same
03/18/2009CN101386839A A device
03/17/2009US7504481 TRP channel family member, LTRPC3 polypeptides
03/17/2009US7504382 Protease inhibitors for coronaviruses and SARS-CoV and the use thereof
03/17/2009US7504259 Nucleotide sequences coding oxidoreductase for use in transfer, expression and production of omega-3 and omega-6 fatty acids in yarrowia
03/12/2009US20090070901 Modified rubisco large subunit n-methyltransferase useful for targeting molecules to the active-site vicinity of ribulose-1, 5-bisphosphate
03/12/2009US20090068152 Gene transfer for regulating smooth muscle tone
03/05/2009US20090060797 Fluid control structures in microfluidic devices
03/04/2009EP1623227A4 Proteins, sensors, and methods of characterizing analytes using the same
03/03/2009US7498428 Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
03/03/2009US7498346 Chemokine receptor binding compounds
03/03/2009US7498305 Activated protein C variants with normal cytoprotective activity but reduced anticoagulant activity
03/03/2009US7498026 Nucleotide sequence encoding an acyltransferase polypeptide comprising membrane-spanning region; immobilization, freeze drying; contacting vegetable oil with polypeptide wherein fatty acids are transferred from phospholipid to an acceptor molecule; ester interchange; lecithin is converted to lysolecithin
03/03/2009US7498024 Expression vector comprising nucleotide sequences coding foot and mouth viral, as well as, immunoglobulin sequences for use in generation imunotherapeutics
02/2009
02/26/2009US20090053227 Prostate Specific Genes and The Use Thereof in Design of Therapeutics
02/26/2009US20090050854 Organic Species that Facilitate Charge Transfer to or from Nanostructures
02/25/2009EP2028278A1 RNA sequence-specific mediators of RNA interference
02/25/2009CN101374948A Variant humicola grisea CBH1.1
02/25/2009CN101371923A BAFF receptor (BCMA), an immunoregulatory agent
02/24/2009US7494982 Modified oligonucleotides for telomerase inhibition
02/24/2009US7494812 Transforming lymphocytes with vector comprising gene sequences which code cytolethal distending toxin (cdt), leukotoxins and heat shock protein and generating regulatory cell which can be used to treat and/or prevent transplant rejection, autoimmune and inflammatory diseases; immunotherapy
02/24/2009US7494796 Site directed mutagenesis; orthogonal tRNAs, orthogonal aminoacyl-tRNA synthetases; cells
02/24/2009US7494789 Annealing double stranded RNA polymerase promoter to oligodeoxynucleotide tail by complementary base pairing, ligating 5' end of antisense strand of double stranded RNA polymerase promoter to 3' end of oligodeoxynucleotide tail, and initiating transcription; gene expression analysis; microarrays; kits
02/24/2009US7494774 Assay and compositions for detection of Bacillus anthracis nucleic acid
02/24/2009US7494644 contacting a myocardial cells with genetic engineered mammalian cells modified to express a connexin 43 proteins, to establishing electrical coupling between cardiomyocytes and recombinant cells; treatment of cardiac disease or tissue repair
02/19/2009US20090049562 Porcine cmp-n-acetylneuraminic acid hydroxylase gene
02/18/2009EP2026072A1 Cromatographic assay system
02/18/2009EP1660634A4 P16 mediated regulation of nmda receptors
02/18/2009CN101370819A Glucanases, nucleic acids encoding them and methods for making and using them
02/17/2009US7491793 Influenza virus inhibiting peptides
02/17/2009US7491735 e.g. N-(3-{4-[(4-Bromo-phenyl)-(3-chloro-benzyl)-amino]-piperidin-1-yl}-butyl)-3,5-dichloro-isonicotinamide; viricide, antiinflammation agent; autoimmune diseases; protective effects against infection of target cells by a human immunodeficiency virus (HIV)
02/17/2009US7491531 Randomized libraries of zinc finger proteins
02/17/2009US7491527 Selectively lysis of female epithelial cells and male sperm cells in microfluidic-based integrated cartridge; sonication and DNA typing
02/17/2009US7490437 Ruminant feed ration containing feed components characterized in real time
02/17/2009CA2138928C Immunoconjugates
02/12/2009WO2005071059A3 Methods of identifying putative gene products by interspecies sequence comparison and biomolecular sequences uncovered thereby
02/12/2009US20090041796 Surface protein of leptospira
02/11/2009EP1636340A4 Unnatural reactive amino acid genetic code additions
02/05/2009US20090036479 Method of inhibiting choroidal neovascuarization
02/05/2009US20090036381 Treatment of diabetes
02/05/2009US20090036321 Methods for predicting the course of a malignant disease
02/03/2009US7485418 Aberrantly methylated genes in pancreatic cancer
02/03/2009US7485291 Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof
02/03/2009CA2440504C Magnetic pigment
01/2009
01/29/2009US20090030185 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
01/27/2009US7482357 N-(pyridin-2-ylmethyl)-4-methyl-3-oxo-4-aza-5 alpha -androst-1-en-17 beta -acetamide; enhancement of weakened muscle tone; osteoporosis, bone disorders; ; periodontal disease, frailty, aging skin, male hypogonadism, postmenopausal symptoms, inflammatory arthritis, cachexia, Alzheimer's disease
01/22/2009US20090023592 System for identifying and analyzing expression of are-containing genes
01/22/2009US20090023216 Double-Stranded Oligonucleotides
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 ... 100